Literature DB >> 17200144

IL-4 induces a wide-spectrum intracellular signaling cascade in CD8+ T cells.

Ana Acacia de Sa Pinheiro1, Alexandre Morrot, Sumana Chakravarty, Michael Overstreet, Jay H Bream, Pablo M Irusta, Fidel Zavala.   

Abstract

IL-4 has distinct effects on the differentiation and functional properties of CD8+ T cells. In vivo studies have shown that it is critical for the development of protective memory responses against tumors and infections by Leishmania and Plasmodium parasites. The intracellular signaling events mediated by IL-4/IL-4 receptor (IL-4R) interactions on CD4+ T cells have been studied extensively; however, the nature of IL-4-induced signaling on CD8+ T cells has not been characterized. Using naïve, activated, as well as differentiated CD8+ T cells, we show that IL-4 has a strong in vivo and in vitro antiapoptotic effect on activated and resting CD8+ T cells. We demonstrate that IL-4 induces the phosphorylation of the IL-4R, which is followed by the activation of at least two distinct intracellular signaling cascades: the Jak1/STAT6 and the insulin receptor substrate/PI-3K/protein kinase B pathways. We also found that IL-4 induces the Jak3-mediated phosphorylation and nuclear migration of STAT1, STAT3, and STAT5 in naïve, activated, as well as differentiated, IFN-gamma-producing CD8+ T cells. The induction of this broad signaling activity in CD8+ T cells coincides with a transcriptional activity of suppressors of cytokine signaling genes, which are decreased significantly in comparison with CD4+ T cells. To our knowledge, this report constitutes the first comprehensive analysis of the signaling events that shape CD8+ T cell responses to IL-4.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200144     DOI: 10.1189/jlb.0906583

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  22 in total

1.  IL-4 acts as a potent stimulator of IFN-γ expression in CD8+ T cells through STAT6-dependent and independent induction of Eomesodermin and T-bet.

Authors:  Jennifer A Oliver; Valerie R Stolberg; Stephen W Chensue; Philip D King
Journal:  Cytokine       Date:  2011-11-09       Impact factor: 3.861

2.  Adjuvant formulations possess differing efficacy in the potentiation of antibody and cell mediated responses to a human malaria vaccine under selective immune genes knockout environment.

Authors:  George S Hui; Caryn N Hashimoto
Journal:  Int Immunopharmacol       Date:  2008-04-03       Impact factor: 4.932

Review 3.  IL-4: an important cytokine in determining the fate of T cells.

Authors:  J L Silva-Filho; C Caruso-Neves; A A S Pinheiro
Journal:  Biophys Rev       Date:  2014-01-09

4.  Increased circulating cytokine levels in African American women with obesity and elevated HbA1c.

Authors:  Ariel Williams; Natasha Greene; K Kimbro
Journal:  Cytokine       Date:  2020-01-28       Impact factor: 3.861

Review 5.  Spectrum of T-lymphocyte activities regulating allergic lung inflammation.

Authors:  Erwin W Gelfand; Anthony Joetham; Meiqin Wang; Katsuyuki Takeda; Michaela Schedel
Journal:  Immunol Rev       Date:  2017-07       Impact factor: 12.988

6.  Neuronal IL-4Rα modulates neuronal apoptosis and cell viability during the acute phases of cerebral ischemia.

Authors:  Han Kyu Lee; Sehwon Koh; Donald C Lo; Douglas A Marchuk
Journal:  FEBS J       Date:  2018-05-24       Impact factor: 5.542

7.  IL-9 induces CCL11 expression via STAT3 signalling in human airway smooth muscle cells.

Authors:  Akira Yamasaki; Ali Saleh; Latifa Koussih; Shigeo Muro; Andrew J Halayko; Abdelilah S Gounni
Journal:  PLoS One       Date:  2010-02-12       Impact factor: 3.240

Review 8.  Eicosanoids in the innate immune response: TLR and non-TLR routes.

Authors:  Yolanda Alvarez; Isela Valera; Cristina Municio; Etzel Hugo; Francisco Padrón; Lydia Blanco; Mario Rodríguez; Nieves Fernández; Mariano Sánchez Crespo
Journal:  Mediators Inflamm       Date:  2010-06-15       Impact factor: 4.711

9.  Pancreatic lipase-related protein 2 (PLRP2) induction by IL-4 in cytotoxic T lymphocytes (CTLs) and reevaluation of the negative effects of its gene ablation on cytotoxicity.

Authors:  Bryce N Alves; Jeff Leong; David L Tamang; Viki Elliott; Jillian Edelnant; Doug Redelman; Cherie A Singer; Andrew R Kuhn; Rita Miller; Mark E Lowe; Dorothy Hudig
Journal:  J Leukoc Biol       Date:  2009-05-18       Impact factor: 4.962

10.  Interleukin-4 stimulates proliferation and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR signaling.

Authors:  B A Cardoso; L R Martins; C I Santos; L M Nadler; V A Boussiotis; A A Cardoso; J T Barata
Journal:  Leukemia       Date:  2008-07-03       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.